CNS Disorders  >>  Octagam (intravenous normal human immunoglobulin)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Octagam (intravenous normal human immunoglobulin) / Octapharma
NCT03348618: A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)

Unknown status
4
21
US
IVIG, Octagam 5%
IMMUNOe Research Centers, Octapharma
Pediatric Acute-Onset Neuropsychiatric Syndrome, Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
11/19
03/20

Download Options